Pharmacovigilance of carmustine: distinct neurotoxic and systemic safety signals identified in FAERS

Kaizhi Xu, Meixuan Guo, Huqiang Dong, Mengyuan Cai, Ping Xu · 2026

Read Pharmacovigilance of carmustine: distinct neurotoxic and systemic safety signals identified in FAERS by Kaizhi Xu, Meixuan Guo, Huqiang Dong, Mengyuan Cai, Ping Xu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13474793.txt.

Description

Xu and colleagues mined United States drug safety reports in 2026 for side effects linked to carmustine, a chemotherapy drug used for brain tumors, lymphomas, and stem cell transplant preparation. They pulled every report naming carmustine as the prime suspect from the FDA Adverse Event Reporting System between 2004 and 2024. Statistical signal tests then flagged which problems appeared more often than expected for this drug.

The search covered 718 reports holding 3,091 coded side effect terms, and the strongest signals grouped around the nervous system, blood, and infections in those reports. Rare brain-related terms stood out, including eosinophilic meningitis, air trapped inside the skull, and low pressure inside the skull after treatment with the drug. Reporting patterns also differed by sex, so the authors urge continued monitoring rather than firm claims about cause and effect from these data.

Catalog record

CREATORKaizhi Xu, Meixuan Guo, Huqiang Dong, Mengyuan Cai, Ping Xu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE55 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13474793

Browse the full library · About the Tower of Babel